These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 18280092)
21. A p38 mitogen-activated protein kinase inhibitor protects against renal damage in a non-heart-beating donor model. Doucet C; Milin S; Favreau F; Desurmont T; Manguy E; Hébrard W; Yamamoto Y; Mauco G; Eugene M; Papadopoulos V; Hauet T; Goujon JM Am J Physiol Renal Physiol; 2008 Jul; 295(1):F179-91. PubMed ID: 18448593 [TBL] [Abstract][Full Text] [Related]
22. Trimetazidine protects the energy status after ischemia and reduces reperfusion injury in a rat single lung transplant model. Inci I; Dutly A; Rousson V; Boehler A; Weder W J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1155-61. PubMed ID: 11726890 [TBL] [Abstract][Full Text] [Related]
23. Trimetazidine and N-acetylcysteine in attenuating hind-limb ischemia and reperfusion injuries: experimental study in rats. Da Silveira M; Yoshida WB Int Angiol; 2009 Oct; 28(5):412-7. PubMed ID: 19935597 [TBL] [Abstract][Full Text] [Related]
24. Ischemia preconditioning does not confer resilience to warm ischemia in a solitary porcine kidney model. Orvieto MA; Zorn KC; Mendiola FP; Gong EM; Lucioni A; Mikhail AA; Gofrit ON; Shalhav AL Urology; 2007 May; 69(5):984-7. PubMed ID: 17482956 [TBL] [Abstract][Full Text] [Related]
26. Morg1 heterozygous mice are protected from acute renal ischemia-reperfusion injury. Hammerschmidt E; Loeffler I; Wolf G Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1273-87. PubMed ID: 19726548 [TBL] [Abstract][Full Text] [Related]
27. Protective role of selectin ligand inhibition in a large animal model of kidney ischemia-reperfusion injury. Jayle C; Milinkevitch S; Favreau F; Doucet C; Richer JP; Deretz S; Mauco G; Rabb H; Hauet T Kidney Int; 2006 May; 69(10):1749-55. PubMed ID: 16625150 [TBL] [Abstract][Full Text] [Related]
28. Evidence for a mitochondrial impact of trimetazidine during cold ischemia and reperfusion. Baumert H; Faure JP; Zhang K; Petit I; Goujon JM; Dutheil D; Favreau F; Barrière M; Tillement JP; Mauco G; Papadopoulos V; Hauet T Pharmacology; 2004 May; 71(1):25-37. PubMed ID: 15051920 [TBL] [Abstract][Full Text] [Related]
29. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Faleo G; Neto JS; Kohmoto J; Tomiyama K; Shimizu H; Takahashi T; Wang Y; Sugimoto R; Choi AM; Stolz DB; Carrieri G; McCurry KR; Murase N; Nakao A Transplantation; 2008 Jun; 85(12):1833-40. PubMed ID: 18580478 [TBL] [Abstract][Full Text] [Related]
30. Early urinary biomarkers of warm and cold ischemic injury in an experimental kidney model. Hosgood SA; Hunter JP; Nicholson ML J Surg Res; 2012 May; 174(2):e85-90. PubMed ID: 22221604 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats. Yoon JW; Cho BJ; Park HS; Kang SM; Choi SH; Jang HC; Shin H; Lee MJ; Kim YB; Park KS; Lim S Int J Cardiol; 2013 Jul; 167(1):126-33. PubMed ID: 22240760 [TBL] [Abstract][Full Text] [Related]
32. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. Torras J; Cruzado JM; Riera M; Condom E; Duque N; Herrero I; Merlos M; Espinosa L; Lloberas N; Egido J; Grinyó JM Kidney Int; 1999 Nov; 56(5):1798-808. PubMed ID: 10571788 [TBL] [Abstract][Full Text] [Related]
33. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia. Ikizler M; Dernek S; Sevin B; Kural T Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878 [TBL] [Abstract][Full Text] [Related]
34. The effect of warm ischemic time on renal function and injury in the isolated hemoperfused kidney. Harper SJ; Hosgood SA; Waller HL; Yang B; Kay MD; Goncalves I; Nicholson ML Transplantation; 2008 Aug; 86(3):445-51. PubMed ID: 18698249 [TBL] [Abstract][Full Text] [Related]